v3.26.1
CONTINGENT CONSIDERATION AND INTANGIBLE ASSET (Details Narrative) - USD ($)
$ in Thousands
6 Months Ended
Oct. 20, 2025
Jun. 30, 2026
Contingent consideration   $ 54
Accrued expenses and other payables   1,546
Ciro Leonardo Pierri [Member] | Maximum [Member]    
Maximum amount payable $ 1,600 $ 1,600
MitoCareX Bio Ltd [Member]    
Shares issued for acquisitions 139,520 34,880
Business combination consideration   $ 385
MitoCareX Bio Ltd [Member] | Ciro Leonardo Pierri [Member]    
Sale of stock percentage 30.00%  
MitoCareX Bio Ltd [Member]    
Subsidiary, ownership percentage, parent 25.00%